Medical device CRO Factory buys MileStone Research Organization for North America expansion

U.S. roadmap
Medical devices-focused CRO Factory has expanded in North America with the acquisition of Milestone.

The Netherlands-based medical devices-focused CRO Factory has acquired Milestone Research Organization, expanding its footprint in North America.

“MileStone is an excellent fit therapeutically, as well as culturally,” said Factory CEO Dirk Meijer, M.D., Ph.D., in a statement. “Milestone’s extensive expertise in orthopedics, neurological and IVD clinical trials, as well as their reimbursement and site management service offerings, is a fantastic value-add for all our clients.”

What’s more, the addition of San Diego-based Milestone builds on Factory’s existing U.S. presence in Austin, Texas, and Princeton, New Jersey. Besides California, the company now has branches in Minnesota and the city of Chicago.

Whitepaper

Overcoming Risk in Oncology Drug Development

Oncology drug development is full of potential obstacles and risks, and you must carefully plan each step. Download this whitepaper for tips on finding the fast track. Premier Research. Built for Biotech.

Operational in over 20 countries worldwide, Factory now offers medical device companies services in data management, consultancy regarding study design and budget and regulatory strategy, regulatory filings, clinical trial monitoring and reimbursement.

Since 1992, the company has completed more than 450 projects in Class II and Class III medical devices and in vitro diagnostic device (IVD), which span a wide range of therapeutic areas, including abdominal, cardiovascular, bone and joint and cardiothorax surgery, as well as interventional radiology, urology, diabetes and dermatology, etc.

According to Factory’s webpage, MileStone founder Kevin Liang, Ph.D., has transitioned to the role of chief clinical officer within the company.

Suggested Articles

The FDA approved the first spinal tether to correct the most common form of scoliosis—a ropelike implant that pulls the vertebrae into shape.

Agilent launched a new analyzer for research that observes cell behavior in real time while also collecting biosensor information.

Five years after Congress passed a law to reduce unnecessary MRIs and CT scans, federal officials have yet to implement it.